Tijaria Polypipes reports net loss of ₹128.72 lakh in FY26
Tijaria Polypipes reported a net loss of ₹128.72 lakh for FY26 with zero operational revenue. Auditors issued a disclaimer of opinion due to significant loan defaults, lack of audit evidence, and non-provision of taxes. The company faces operational halts and compliance issues, with directors funding operations personally.

*this image is generated using AI for illustrative purposes only.
Tijaria Polypipes Limited reported a net loss of ₹128.72 lakh for the financial year ended March 31, 2026, as revenue from operations remained nil. The company’s Board of Directors approved the audited financial results for the quarter and year ended March 31, 2026, on May 26, 2026. The filing reveals a continued financial strain with total expenses amounting to ₹151.01 lakh for the year, primarily driven by finance costs and depreciation.
Financial Performance
The company recorded a total income of ₹22.29 lakh for FY26, solely from other income, compared to ₹29.78 lakh in the previous year. For the quarter ended March 31, 2026, the net loss stood at ₹29.92 lakh. The basic and diluted earnings per share (EPS) for the year were reported at -₹0.45. The paid-up equity share capital remained unchanged at ₹2,862.66 lakh.
| Particulars | Year Ended 31.03.2026 (Audited) | Year Ended 31.03.2025 (Audited) |
|---|---|---|
| Total Income | 22.29 | 29.78 |
| Revenue from Operations | - | - |
| Other Income | 22.29 | 29.78 |
| Total Expenses | 151.01 | 260.24 |
| Finance Cost | 48.85 | 1.79 |
| Depreciation | 76.31 | 230.67 |
| Net Profit/(Loss) | -128.72 | -543.01 |
| Earnings Per Share (Basic) | -0.45 | -1.90 |
Auditor’s Disclaimer of Opinion
Amit Ramakant & Co., the statutory auditor, issued a disclaimer of opinion on the standalone financial results. The report highlights significant material uncertainties, including a default on loans amounting to ₹54.56 crore with Bank of India, which has been classified as a Non-Performing Asset (NPA). The auditor noted that the bank has forfeited equity shares worth ₹540.27 lakh belonging to promoters and directors.
The report further states that the management has not made interest provisions on the NPA account since July 1, 2022. Additionally, independent balance confirmations for receivables and advances totaling ₹2,517 lakh were not received, and no interest was accrued on these amounts. The auditor also pointed out that income tax, including deferred tax, has not been determined or provided for the financial year.
Operational and Compliance Issues
The auditor emphasized that there was no production of goods during the quarter. The company’s bank accounts were seized by the bank due to NPA status, forcing directors to make payments and receipts on behalf of the company from their personal accounts, a practice noted as a violation of Section 269SS of the Income Tax Act, 1961.
Physical verification of fixed assets was not conducted by the management. The textile segment, which has been closed for a long time, reported gross assets of ₹83.98 crore and a net block of ₹12.15 crore. The management stated that it intends to resume production once market conditions and finances improve.
Related Party Transactions
The company disclosed outstanding unsecured loans of ₹838.19 lakh from Key Management Personnel as of March 31, 2026. Additionally, the company took an additional loan of ₹5 crore from directors and ₹7 crore from M/s Nakshetra Asset Venture Limited, Nagpur, at 8% per annum to deposit with Bank of India for a potential One Time Settlement (OTS). The next hearing for the NCLT case regarding the company’s insolvency proceedings is scheduled for March 09, 2026.
Historical Stock Returns for Tijaria Polypipes
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.94% | -2.30% | -7.21% | -12.55% | -42.72% | -56.41% |
What is the likelihood of the One Time Settlement (OTS) with Bank of India succeeding given the company's reliance on high-cost director loans?
How will the National Company Law Tribunal (NCLT) proceedings scheduled for March 2026 impact the company's ability to resume operations?
Can the company effectively restart production without resolving the significant tax compliance violations and auditor disclaimers?
































